Published in Biochem J on January 01, 1988
Metabolism of the inositol phosphates produced upon receptor activation. Biochem J (1989) 2.64
The purification and properties of myo-inositol monophosphatase from bovine brain. Biochem J (1988) 1.80
Plant inositol monophosphatase is a lithium-sensitive enzyme encoded by a multigene family. Plant Cell (1995) 1.47
Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology (2010) 1.25
cDNA cloning of human and rat brain myo-inositol monophosphatase. Expression and characterization of the human recombinant enzyme. Biochem J (1992) 1.23
Two dephosphorylation pathways of inositol 1,4,5-trisphosphate in homogenates of the cellular slime mould Dictyostelium discoideum. Biochem J (1988) 1.23
Accumulation of inositol polyphosphate isomers in agonist-stimulated cerebral-cortex slices. Comparison with metabolic profiles in cell-free preparations. Biochem J (1989) 1.22
Hydrolysis of inositol phosphates by plant cell extracts. Biochem J (1989) 1.20
Mechanism of inositol monophosphatase, the putative target of lithium therapy. Proc Natl Acad Sci U S A (1994) 1.18
The inhibition of phosphoinositide synthesis and muscarinic-receptor-mediated phospholipase C activity by Li+ as secondary, selective, consequences of inositol depletion in 1321N1 cells. Biochem J (1994) 1.05
Rapid accumulation and sustained turnover of inositol phosphates in cerebral-cortex slices after muscarinic-receptor stimulation. Biochem J (1989) 0.99
Purification and properties of inositol-1,4-bisphosphatase from bovine brain. Biochem J (1988) 0.99
Modification of myo-inositol monophosphatase by the arginine-specific reagent phenylglyoxal. Biochem J (1989) 0.89
Phospholipid synthesis participates in the regulation of diacylglycerol required for membrane trafficking at the Golgi complex. J Biol Chem (2011) 0.86
Mammalian inositol monophosphatase: the identification of residues important for the binding of Mg2+ and Li+ ions using fluorescence spectroscopy and site-directed mutagenesis. Biochem J (1993) 0.84
A monoclonal antibody to bovine brain inositol monophosphatase. Immunoaffinity purification of the brain and kidney enzymes and evidence for their structural identity. Biochem J (1989) 0.83
Metabolism of inositol phosphates in ATP-stimulated vascular endothelial cells. Biochem J (1991) 0.81
Bovine inositol monophosphatase. Modification, identification and mutagenesis of reactive cysteine residues. Biochem J (1992) 0.80
Subcellular localization of the enzymes that dephosphorylate myo-inositol polyphosphates in human platelets. Biochem J (1988) 0.80
Analysis of [3H]inositol phosphate formation and metabolism in cerebral-cortical slices. Evidence for a dual metabolism of inositol 1,4-bisphosphate. Biochem J (1992) 0.79
Limited proteolysis and 'in vitro' mutagenesis of bovine brain inositol monophosphatase identifies an N-terminal region important for activity. Biochem J (1990) 0.79
Inhibition of agonist-stimulated inositol lipid metabolism by the anticonvulsant carbamazepine in rat hippocampus. Br J Pharmacol (1989) 0.79
Inositol phosphate formation and its relationship to calcium signaling. Environ Health Perspect (1990) 0.78
Dephosphorylation of 1D-myo-inositol 1,4-bisphosphate in rat liver. Biochem J (1988) 0.76
Identification of mitogen-activated protein kinase docking sites in enzymes that metabolize phosphatidylinositols and inositol phosphates. Cell Commun Signal (2006) 0.75
Inositol trisphosphate and diacylglycerol as second messengers. Biochem J (1984) 14.37
The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane. Biochem J (1982) 6.82
The polyphosphoinositide phosphodiesterase of erythrocyte membranes. Biochem J (1981) 6.16
The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem (1980) 6.02
The inositol tris/tetrakisphosphate pathway--demonstration of Ins(1,4,5)P3 3-kinase activity in animal tissues. Nature (1986) 5.41
Micro-injection of inositol 1,3,4,5-tetrakisphosphate activates sea urchin eggs by a mechanism dependent on external Ca2+. Biochem J (1986) 4.84
A new micromethod for the colorimetric determination of inorganic phosphate. Clin Chim Acta (1966) 4.39
The second messenger linking receptor activation to internal Ca release in liver. Nature (1984) 3.73
Stepwise enzymatic dephosphorylation of inositol 1,4,5-trisphosphate to inositol in liver. Nature (1984) 3.46
Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. Pharmacol Rev (1986) 3.15
Formation and metabolism of inositol 1,3,4,5-tetrakisphosphate in liver. J Biol Chem (1986) 2.81
D-myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specific phosphatase in rat testis. J Biol Chem (1967) 2.61
Dephosphorylation of myo-inositol 1,4,5-trisphosphate and myo-inositol 1,3,4-triphosphate. Biochem J (1987) 1.98
Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat. J Neurochem (1981) 1.94
Ca2+ regulates the inositol tris/tetrakisphosphate pathway in intact and broken preparations of insulin-secreting RINm5F cells. J Biol Chem (1986) 1.91
Phosphoinositide interconversion in thrombin-stimulated human platelets. J Biol Chem (1985) 1.74
Evidence that inositol 1-phosphate in brain of lithium-treated rats results mainly from phosphatidylinositol metabolism. Biochem J (1987) 1.70
Purification and properties of myo-inositol-1-phosphatase from rat brain. J Biochem (1985) 1.62
Pathway for inositol 1,3,4-trisphosphate and 1,4-bisphosphate metabolism. Proc Natl Acad Sci U S A (1987) 1.53
Inositol bis-, tris-, and tetrakis(phosphate)s: analysis in tissues by HPLC. Proc Natl Acad Sci U S A (1986) 1.38
Phosphatidylinositol 4,5-bisphosphate turnover is transient while phosphatidylinositol turnover is persistent in thyrotropin-releasing hormone-stimulated rat pituitary cells. Proc Natl Acad Sci U S A (1986) 1.32
Angiotensin-stimulated production of inositol trisphosphate isomers and rapid metabolism through inositol 4-monophosphate in adrenal glomerulosa cells. Proc Natl Acad Sci U S A (1986) 1.28
Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis. J Neurochem (1985) 1.26
Evidence for the formation of inositol 4-monophosphate in stimulated human platelets. FEBS Lett (1985) 1.21
Enzymic dephosphorylation of D-myo-inositol 1,4-bisphosphate in rat brain. Biochem J (1987) 1.03
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Continuity of care and trust in one's physician: evidence from primary care in the United States and the United Kingdom. Fam Med (2001) 4.54
Comparison of standards in training and non-training practices. J R Coll Gen Pract (1985) 4.44
Qualitative methods in research on healthcare quality. Qual Saf Health Care (2002) 4.42
What do we know about how to do audit and feedback? Pitfalls in applying evidence from a systematic review. BMC Health Serv Res (2005) 3.51
Impact of the population at risk of diabetes on projections of diabetes burden in the United States: an epidemic on the way. Diabetologia (2006) 3.28
Changing the clinical behavior of doctors: a psychological framework. Qual Health Care (1996) 3.22
Electrotonic coupling between neurons in cat inferior olive. J Neurophysiol (1974) 3.20
Model for directly assessing and improving clinical competence and performance in revalidation of clinicians. BMJ (2001) 3.05
Features of primary care associated with variations in process and outcome of care of people with diabetes. Br J Gen Pract (2001) 2.95
Clozapine for the treatment of adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry (1992) 2.68
Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2005) 2.46
Differentiating between audit and research: postal survey of health authorities' views. BMJ (1999) 2.41
Quality improvement research: understanding the science of change in health care. Qual Saf Health Care (2002) 2.41
Differentiation of atypical atrioventricular node re-entrant tachycardia from orthodromic reciprocating tachycardia using a septal accessory pathway by the response to ventricular pacing. J Am Coll Cardiol (2001) 2.40
Left in limbo: patients' views on care across the primary/secondary interface. Qual Health Care (1999) 2.38
Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci (2001) 2.38
Jumonji, a nuclear protein that is necessary for normal heart development. Circ Res (2000) 2.26
A split binding site for transcription factor tau on the tRNA3Glu gene. EMBO J (1985) 2.16
In vivo intracellular recording and perturbation of persistent activity in a neural integrator. Nat Neurosci (2001) 2.13
A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res (1998) 2.12
Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review. Diabet Med (2000) 2.10
Metastatic malignant mesothelioma presenting as colonic polyps. Hum Pathol (1997) 2.09
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A (1988) 1.99
Dopamine receptors in rat striatum and nucleus accumbens; conformational studies using rigid analogues of dopamine. J Pharm Pharmacol (1977) 1.95
Effects of treatment with formoterol on bronchoprotection against methacholine. Am J Med (1998) 1.94
A monoclonal antibody to kidney endopeptidase-24.11. Its application in immunoadsorbent purification of the enzyme and immunofluorescent microscopy of kidney and intestine. Biochem J (1983) 1.91
Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography. Biochem J (1983) 1.85
Features of primary health care teams associated with successful quality improvement of diabetes care: a qualitative study. Fam Pract (2001) 1.84
The purification and properties of myo-inositol monophosphatase from bovine brain. Biochem J (1988) 1.80
Quality assurance in general practice: the state of the art in Europe. Fam Pract (1994) 1.75
Best place of care for older people after acute and during subacute illness: a systematic review. J Health Serv Res Policy (2000) 1.75
The costs and benefits of asking patients for their opinions about general practice. Fam Pract (1996) 1.73
Development of guidelines to facilitate improved support of South Asian carers by primary health care teams. Qual Health Care (2001) 1.72
Structural study of inferior olivary nucleus of the cat: morphological correlates of electrotonic coupling. J Neurophysiol (1974) 1.71
Characteristics of general practices associated with emergency admission rates to hospital: a cross-sectional study. Emerg Med J (2011) 1.65
Introducing a quality improvement programme to primary healthcare teams. Qual Health Care (1998) 1.64
A strategy for validation of bioanalytical methods. J Pharm Biomed Anal (1996) 1.64
Working from upstream to improve health care: the IHI interdisciplinary professional education collaborative. Jt Comm J Qual Improv (1996) 1.61
Cinephotomicroscopy of Normal Blood Circulation in the Cheek Pouch of the Hamster. Science (1947) 1.58
Is it time to review the idea of compliance with guidelines? Br J Gen Pract (2001) 1.56
The glycine site of the NMDA receptor--five years on. Trends Pharmacol Sci (1993) 1.54
Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev (2006) 1.47
Effective treatment of an elderly patient with Gaucher's disease and Parkinsonism: a case report of 24 months' oral substrate reduction therapy with miglustat. Parkinsonism Relat Disord (2006) 1.46
Hospitalists for the NHS? J R Soc Med (2000) 1.46
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A (2010) 1.45
Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabet Med (2007) 1.45
Dupuytren's contracture unfolded. BMJ (2006) 1.45
Crisis, ethics, and the American Medical Association 1847 and 1997. JAMA (1997) 1.44
3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J Med Chem (1996) 1.44
Use of a single solution for oral rehydration and maintenance therapy of infants with diarrhea and mild to moderate dehydration. Pediatrics (1995) 1.43
Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines. J Med Chem (1989) 1.42
Synthesis of combinatorial libraries of 3,4,5-trisubstituted 2(5H)-furanones. Part Two: Construction of a library of 4-amino-5-alkoxy-2(5H)-furanones. Drug Des Discov (1999) 1.39
Electrotonic coupling between neurones in the rat mesencephalic nucleus. J Physiol (1971) 1.39
Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas (1986) 1.38
An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. Biochem J (1985) 1.37
Collation and comparison of multi-practice audit data: prevalence and treatment of known diabetes mellitus. Br J Gen Pract (1999) 1.36
The circular genetic map of phage S13. Proc Natl Acad Sci U S A (1967) 1.36
Potentially avoidable emergency department attendance: interview study of patients' reasons for attendance. Emerg Med J (2011) 1.35
Biosynthesis of ethylene from methionine. Isolation of the putative intermediate 4-methylthio-2-oxobutanoate from culture fluids of bacteria and fungi. Biochem J (1979) 1.35
Quality of care of patients with diabetes: collation of data from multi-practice audits of diabetes in primary care. Fam Pract (1999) 1.34
A survey of audit activity in general practice. Br J Gen Pract (1998) 1.34
A systematic review of discharge arrangements for older people. Health Technol Assess (2002) 1.33
Multicomponent alarm pheromones of the weaver ant. Nature (1975) 1.33
Learning from complaints about general practitioners. BMJ (1999) 1.33
Neuronal activity in prepositus nucleus correlated with eye movement in the alert cat. J Neurophysiol (1982) 1.32
Studies of intestinal lymphoid tissue. XII. Epithelial lymphocyte and mucosal responses to rectal gluten challenge in celiac sprue. Gastroenterology (1989) 1.30
Novel 5-HT3 antagonists. Indole oxadiazoles. J Med Chem (1991) 1.30
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureas. J Med Chem (1996) 1.29
Tetrahydropyridyloxadiazoles: semirigid muscarinic ligands. J Med Chem (1991) 1.29
Effect of age on thickness of adult patellar articular cartilage. Ann Rheum Dis (1977) 1.28
Anatomy and discharge properties of pre-motor neurons in the goldfish medulla that have eye-position signals during fixations. J Neurophysiol (2000) 1.27
Proteins of the kidney microvillar membrane. The 130 kDa protein in pig kidney, recognized by monoclonal antibody GK5C1, is an ectoenzyme with aminopeptidase activity. Biochem J (1985) 1.24
Blockage of inhibition by ammonium acetate action on chloride pump in cat trochlear motoneurons. J Neurophysiol (1974) 1.23
The impact of self-presentation and interviewer bias effects on self-reported heroin use. Br J Addict (1987) 1.22
Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis (2000) 1.21
Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations. Br J Gen Pract (2000) 1.21
Sexual dimorphisms in the vocal control system of a teleost fish: morphology of physiologically identified neurons. J Neurobiol (1990) 1.20
Sector mastectomy in selected cases of breast cancer. Br J Surg (1971) 1.20
Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol (1993) 1.20
Bacteriophage S13: a 7th gene. Science (1967) 1.20
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Cell Immunol (1999) 1.19
Eye position and eye velocity integrators reside in separate brainstem nuclei. Proc Natl Acad Sci U S A (1994) 1.18
Failure to vaccinate against whooping cough. Arch Dis Child (1986) 1.18
Mechanism of inositol monophosphatase, the putative target of lithium therapy. Proc Natl Acad Sci U S A (1994) 1.18
Correction of severe crouch gait in patients with spastic diplegia with use of multilevel orthopaedic surgery. J Bone Joint Surg Am (2006) 1.18
Vocal-acoustic pathways in a teleost fish. J Neurosci (1994) 1.17
Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors. J Med Chem (1990) 1.16
Fabry disease in unselected patients with TIA or stroke: population-based study. Eur J Neurol (2012) 1.16
Cloning and deletion mutagenesis of the alpha2 delta calcium channel subunit from porcine cerebral cortex. Expression of a soluble form of the protein that retains [3H]gabapentin binding activity. J Biol Chem (1998) 1.15
Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J Clin Invest (1993) 1.15
Effective audit in general practice: a method for systematically developing audit protocols containing evidence-based review criteria. Br J Gen Pract (1997) 1.13
Blinking and associated eye movements in humans, guinea pigs, and rabbits. J Neurophysiol (1984) 1.13
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. J Thromb Haemost (2010) 1.12